Trial Profile
A Randomised, Double-blinded, Cross-over Study Investigating the Short-term Impact of Liraglutide on Kidney Function in Diabetic Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
- 27 Feb 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 03 Nov 2012 New source identified and integrated (European Clinical Trials Database record: EudraCT2012-003577-26).